PROVECTUS BIOPHARMACEUTICALS INC WTS (DE)
PVCT.WS
PVCT.WS was delisted on the 13th of October, 2016.
0 hedge funds and large institutions have $0 invested in PROVECTUS BIOPHARMACEUTICALS INC WTS (DE) in 2016 Q4 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, reducing their positions, and 4 closing their positions.
100% less funds holding
Funds holding: 4 → 0 (-4)
100% less capital invested
Capital invested by funds: $149K → $0 (-$149K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 4
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$114K |
| 2 |
Millennium Management
New York
|
-$26K |
| 3 |
Creative Planning
Overland Park,
Kansas
|
-$8K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CAM
1
Cormorant Asset Management
Boston,
Massachusetts
| – | -$114K | -2,200,000 | Closed |
|
|
2
Millennium Management
New York
| – | -$26K | -500,000 | Closed |
|
|
3
Creative Planning
Overland Park,
Kansas
| – | -$8K | -149,570 | Closed |
|
|
4
UBS Group
Zurich,
Switzerland
| – | -$1K | -9,926 | Closed |
|
PVCT.WS Hedge Fund Activity: Q4 2016 in Review
0 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in PROVECTUS BIOPHARMACEUTICALS INC WTS (DE) (PVCT.WS) for Q4 2016, worth a combined $0 — down 100% from $149K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of PVCT.WS and 0 opened new positions — a net loss of 4 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Cormorant Asset Management, exiting entirely with an estimated $114K sold.
- 0 institutional investors held PROVECTUS BIOPHARMACEUTICALS INC WTS (DE) (PVCT.WS) as of Q4 2016, down from 4 in Q3 2016.
- Funds reported $0 of PROVECTUS BIOPHARMACEUTICALS INC WTS (DE) stock for Q4 2016, down 100% quarter-over-quarter.
- 0 funds opened new PROVECTUS BIOPHARMACEUTICALS INC WTS (DE) positions in Q4 2016 and 4 closed out, a net change of -4 holders.
- The largest PROVECTUS BIOPHARMACEUTICALS INC WTS (DE) seller in Q4 2016 was Cormorant Asset Management, an estimated $114K sold.
Based on aggregated 13F filings for Q4 2016.